Mode
Home
Conditions Medications Drug Pipeline Weekly Digests Questions
Text Size
Log in / Sign up
Home › Questions › Genetics & Precision Medicine

Can a specific saliva test accurately predict my risk for nasopharyngeal carcinoma?

high confidence  ·  Last reviewed May 13, 2026

Nasopharyngeal carcinoma (NPC) is a type of head and neck cancer strongly linked to Epstein-Barr virus (EBV) infection. Researchers have developed a saliva test that looks for antibodies against a specific EBV protein called EBNA1. This test can identify people at higher risk for NPC years before diagnosis, making it a promising screening tool, especially in regions where NPC is common.

What the research says

A 2024 study tested a new strip assay called EBNA1 SeroStrip-HT using saliva samples from people who later developed NPC and healthy controls 3. The test measured IgA antibodies to different forms of the EBNA1 protein. For the mammalian-derived EBNA1 dGAr version, the test had 85.0% sensitivity (correctly identifying those with NPC) and 94.8% specificity (correctly ruling out those without NPC) 3. When using insect-derived EBNA1 full-length (FL) protein, sensitivity reached 90% but specificity was slightly lower at 91.7% 3. Combining results for both EBNA1 FL and dGAr gave an odds ratio of 243.67 for NPC risk in people positive for both 3.

Another large meta-analysis of over 7,750 saliva samples confirmed that saliva-based models can predict NPC with high accuracy, achieving AUC values of 0.898–0.995 for certain models 4. This supports the idea that saliva biomarkers are reliable for non-invasive screening.

A mini review also notes that EBNA1 is a consistent marker linked to NPC susceptibility, along with other EBV markers like LMP1 and plasma EBV DNA 5. These findings highlight the potential of EBNA1-based saliva tests for population screening.

What to ask your doctor

  • Is the EBNA1 SeroStrip-HT saliva test available or recommended for NPC screening in my region?
  • How does my personal risk (e.g., family history, EBV status) affect the usefulness of this test for me?
  • If I test positive, what follow-up steps (e.g., nasal endoscopy, imaging) would you recommend?
  • Are there other validated screening methods for NPC that I should consider alongside saliva testing?

This question is drawn from common patient questions about Genetics & Precision Medicine and answered using cited medical research. We do not provide individualized advice.